Novozymes (NVZMY)
(Delayed Data from OTC)
$63.85 USD
+0.98 (1.56%)
Updated Aug 13, 2024 03:59 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Industry / Sector Report
Industry : Chemical - Specialty
Zacks Industry Rank
Bottom 38% (156 out of 250)Zacks Sector Rank
Bottom 25% (12 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 2.13 | 9.99 |
Current Quarter Estimate | NA | 2.06 | 61.00 |
Year Ago Quarter Estimate | 0.32 | 0.76 | 54.84 |
Next Quarter Estimate | NA | 1.98 | 63.00 |
Next Year Estimate | 2.13 | 9.65 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 15.19 | 15.00 | 15.67 |
Next Year | 17.03 | 20.60 | 11.34 |
Last 5 Years | -1.00 | 4.00 | 8.10 |
Next 5 Years | 9.80 | 14.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 40.41 | 52.82 |
Price/Book (MRQ) | 14.35 | 2.11 |
Price/Cash Flow (MRFY) | 67.79 | 11.10 |
Dividend Yield | 0.89% | 0.90% |
Net Profit Margin (TTM) | 16.88% | 7.01% |
Return on Equity (TTM) | 21.42% | 13.33% |
Debt to Equity (MRQ) | NA | 37.50 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.